Abbott Laboratories SWOT Analysis Strength 1. Abbott is collaborating with Syngene, India's leading contract research organization, to establish its first nutrition research and development (R&D) center in the country 2. Abbott Molecular has acquired an exclusive license to develop a diagnostic test in the United States based on several new biomarkers 3. Includes a broad range of specialized medicines; medical diagnostic instruments and tests; minimally invasive surgical devices; a spectrum of nutritional supplements for infants, children and adults; and products for veterinary care. 4. Abbott Launches PediaSure SideKicks , a nutritional beverage to help balance out a picky eater's uneven diet 5.Strong employee force of 90,000 Weakness 1. Products listed on the site may be available only in certain countries. 2.Company is overly dependent upon mature products whose patents may expire in near future 3. Abbot faces lot of litigation cases in various countries regarding its products 4. Upcoming patent expires Opportunity 1. Broad-based medical innovation, in technologies and businesses across the spectrum of health care 2. Pioneering solutions that advance health care 3. Address health needs in under-developed and poor countries 4. Leverage its core business expertise and resources to create sustainable solutions in countries around the world. Threats 1. Increasing obsolesce of technology 2. Competition from peers 3.Unprecedented generic erosion exacerbated by ineffective product lifecycle launches 4.Government regulation 5.Industry consolidation

2. ABBOTT
LABORATORIES

3. GROUP LEARDER
•JUNAID KHALIL

4. HISTORY
• Global Pharmaceuticals And Health
Care Products Company
• 90,000 Employees And Operates In Over
130 Countries
• Headquarters
• Founded By Chicago Physician, Dr.
Wallace Calvin Abbott In 1888
• In 2010 Over $35 Billion In Revenue.

5. HISTORY
• In 1985, The Company Developed The
First HIV Blood Screening Test.
• Company's Drug Portfolio Disease
• Broad Range Of Medical Devices
• Diagnostics And Immunoassay Products
As Well As Nutritional Products
• Including Ensure

6. HISTORY
• A Line
• Meal Replacement Shakes
• And EAS
• Nutritional Supplements.
• World Leader Blood Screening.
• Medical Tests Diagnostic Instrument
Systems Used Worldwide

7. HISTORY
• Hospitals, Laboratories, Blood Banks, And
Physician Offices To Diagnose
• HIV, Hepatitis, Cancer, Heart Failure And
Metabolic Disorders
• Abbott Point-of-care Manufactures
Diagnostic Products For Blood Analysis
• Emergency Room

8. WORKING
• Animal Health
• Diabetes Care
• Diagnostics
• Analysis Of DNA
• Nutrition

9. MARYAM NAEEM

10. Vision & Mission
• Vision
To be the Most Admired Healthcare Company
in Pakistan.
• Mission
To deliver consistently superior products and
services which contribute significantly to
improving the quality of life for consumers

11. INFORMATION
• Board Of Directors
• City Office
• Registered Office
• Website
• Senior Management Team
• *Arshad Saeed Husain has replaced Asif
Jooma as CEO effective 25 Febuary 2013.
Abbott Pakistan Annual Report 2012

12. HASSAN
RAO

13. SHAREHOLDERS
AUDIT COMMITTEE
CEO
GENERAL
CARE
INTERNAL AUDIT
BANKING
COMMITTEE
SHARETRANSFER
COMMITTEE
HRM
COMMITTEE
OTHERNURTIONALPHARACATICALES
DIABETESDIAGNOSTICS
BOD
MANGEMENT

14. TEHMINA
•

15. Strength
• 1. Abbott is collaborating with Syngene, India's leading contract
research organization, to establish its first nutrition research
and development (R&D) center in the country
• 2. Abbott Molecular has acquired an exclusive license to
develop a diagnostic test in the United States based on several
new biomarkers
• 3. Includes a broad range of specialized medicines; medical
diagnostic instruments and tests; minimally invasive surgical
devices; a spectrum of nutritional supplements for infants,
children and adults; and products for veterinary care.
• 4. Abbott Launches PediaSure SideKicks , a nutritional beverage
to help balance out a picky eater's uneven diet
• 5.Strong employee force of 90,000

16. RIMSHA RANA

17. Weakness
• 1. Products listed on the site may be available
only in certain countries.
• 2.Company is overly dependent upon mature
products whose patents may expire in near
future
• 3. Abbot faces lot of litigation cases in various
countries regarding its products
• 4. Upcoming patent expires

18. •TALHA
HAMEED SHAH

19. Opportunity
• 1. Broad-based medical innovation, in
technologies and businesses across the
spectrum of health care
• 2. Pioneering solutions that advance health care
• 3. Address health needs in under-developed and
poor countries
• 4. Leverage its core business expertise and
resources to create sustainable solutions in
countries around the world.

20. Threats
• 1. Increasing obsolesce of technology
• 2. Competition from peers
• 3.Unprecedented generic erosion
exacerbated by ineffective product
lifecycle launches
4.Government regulation
5.Industry consolidation